Risk Factor Collaboration NCD, (NCD-RisC) (2017) Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet (London, England) 390:2627–2642. https://doi.org/10.1016/S0140-6736(17)32129-3

Article  Google Scholar 

Health Effects of Overweight and Obesity in 195 Countries over 25 Years (2017) N Engl J Med 377(1):13–27. https://doi.org/10.1056/NEJMoa1614362

Connoley IP, Liu YL, Frost I, Reckless IP, Heal DJ, Stock MJ (1999) Thermogenic effects of sibutramine and its metabolites. Br J Pharmacol 126:1487–1495. https://doi.org/10.1038/sj.bjp.0702446

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scheen AJ (2010) Cardiovascular risk-benefit profile of sibutramine: American Journal Cardiovascular. Drugs 10:321–334. https://doi.org/10.2165/11584800-000000000-00000

Article  CAS  Google Scholar 

James WPT, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP et al (2010) Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 363:905–917. https://doi.org/10.1056/NEJMoa1003114

Article  CAS  PubMed  Google Scholar 

Samsky MD, Morrow DA, Proudfoot AG, Hochman JS, Thiele H, Rao SV (2021) Cardiogenic shock after acute myocardial infarction: a review. JAMA 326:1840–1850. https://doi.org/10.1001/jama.2021.18323

Article  PubMed  PubMed Central  Google Scholar 

Morikawa Y, Shibata A, Okumura N, Ikari A, Sasajima Y, Suenami K et al (2017) Sibutramine provokes apoptosis of aortic endothelial cells through altered production of reactive oxygen and nitrogen species. Toxicol Appl Pharmacol 314:1–11. https://doi.org/10.1016/j.taap.2016.11.003

Article  CAS  PubMed  Google Scholar 

Morikawa Y, Shibata A, Sasajima Y, Suenami K, Sato K, Takekoshi Y et al (2018) Sibutramine facilitates apoptosis and contraction of aortic smooth muscle cells through elevating production of reactive oxygen species. Eur J Pharmacol 841:113–121. https://doi.org/10.1016/j.ejphar.2018.10.009

Article  CAS  PubMed  Google Scholar 

Oberholzer HM, Van Der Schoor C, Taute H, Bester MJ (2015) A descriptive study to provide evidence of the teratogenic and cellular effects of sibutramine and ephedrine on cardiac- and liver-tissue of chick embryos. Microsc Res Tech 78:737–746. https://doi.org/10.1002/jemt.22539

Article  CAS  PubMed  Google Scholar 

Eroglu E, Gemici G, Bayrak F, Kalkan AK, Degertekin M (2009) Acute myocardial infarction in a 24 year-old man possibly associated with sibutramine use. Int J Cardiol 137:e43–e45. https://doi.org/10.1016/j.ijcard.2008.06.017

Article  PubMed  Google Scholar 

Ernest D, Gershenzon A, Corallo CE, Nagappan R (2008) Sibutramine-associated QT interval prolongation and cardiac arrest. Ann Pharmacother 42:1514–1517. https://doi.org/10.1345/aph.1L129

Article  CAS  PubMed  Google Scholar 

Shah MS, Patel ZK, Bharucha R, Talati T, Benz M (2022) Sibutramine-induced nonischemic cardiomyopathy. Cureus 14:e21650. https://doi.org/10.7759/cureus.21650

Article  PubMed  PubMed Central  Google Scholar 

Heo SH, Kang M-H (2013) A case of dilated cardiomyopathy with massive left ventricular thrombus after use of a sibutramine-containing slimming product. Korean Circ J 43:632–635. https://doi.org/10.4070/kcj.2013.43.9.632

Article  PubMed  PubMed Central  Google Scholar 

Harrison-Woolrych M, Clark DWJ, Hill GR, Rees MI, Skinner JR (2006) QT interval prolongation associated with sibutramine treatment. Br J Clin Pharmacol 61:464–469. https://doi.org/10.1111/j.1365-2125.2006.02574.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yim K-MA, Ng HW, Chan C-K, Yip G, Lau FL (2008) Sibutramine-induced acute myocardial infarction in a young lady. Clin Toxicol (Phila) 46:877–879. https://doi.org/10.1080/15563650802136258

Article  CAS  PubMed  Google Scholar 

Pöss J, Böhm M, Link A (2010) 32-jährige Patientin mit akutem Myokardinfarkt der Hinterwand unter Einnahme des Appetitzüglers Sibutramin. DMW - Deut Med Wochenschr 135:965–968. https://doi.org/10.1055/s-0030-1253684

Article  Google Scholar 

Azarisman SM, Magdi YA, Noorfaizan S, Oteh M (2007) Myocardial infarction induced by appetite suppressants in Malaysia. N Engl J Med 357:1873–1874. https://doi.org/10.1056/NEJMc070990

Article  CAS  PubMed  Google Scholar 

Gómez-Barrado JJ, Turégano S, Garcipérez de Vargas FJ, Porras Y (2010) Acute coronary syndrome in a young woman treated with sibutramine. Rev Esp Cardiol 63:243

Article  PubMed  Google Scholar 

Rodriguez-Guerra M, Yadav M, Bhandari M, Sinha A, Bella JN, Sklyar E (2021) Sibutramine as a cause of sudden cardiac death. Case Rep Cardiol 2021:8896932. https://doi.org/10.1155/2021/8896932

Article  PubMed  PubMed Central  Google Scholar 

Kim K-S, Kim E-J, Lee H-A, Park S-J (2009) Effect of sibutramine HCl on cardiac hERG K+ channel. Mol Cell Biochem 320:125–131. https://doi.org/10.1007/s11010-008-9914-2

Article  CAS  PubMed  Google Scholar 

Rodriguez-Guerra M, Yadav M, Bhandari M, Sinha A, Bella JN, Sklyar E (2021) Case Rep Cardiol 2021:8896932. https://doi.org/10.1155/2021/8896932

Article  PubMed  PubMed Central  Google Scholar 

Skalicka-Woźniak K, Georgiev MI, Orhan IE (2017) Adulteration of herbal sexual enhancers and slimmers: the wish for better sexual well-being and perfect body can be risky. Food Chem Toxicol 108:355–364. https://doi.org/10.1016/j.fct.2016.06.018

Article  CAS  PubMed  Google Scholar 

Tucker J, Fischer T, Upjohn L, Mazzera D, Kumar M (2018) Unapproved pharmaceutical ingredients included in dietary supplements associated with US Food and Drug Administration warnings. JAMA Netw Open 1:e183337. https://doi.org/10.1001/jamanetworkopen.2018.3337

Article  PubMed  PubMed Central  Google Scholar